Edelman Joseph's Form 4 filing
Adma Biologics, Inc. (ADMA) · filed Sep 30, 2021
- Accession no.
- 0001062993-21-009017
- Filed
- Sep 30, 2021, 7:27 PM ET
- Trade date
- Sep 28-30, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $299.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edelman JosephCIK 0001164426 | 10% Owner |
| Perceptive Advisors LLCCIK 0001224962 | 10% Owner |
| Perceptive Life Sciences Master Fund LtdCIK 0001249675 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2021 | Common Stock | SSaleDisposed | −40,603 | $1.22 | −$49,535.66 | 13,482,375 | Indirect | |
| Sep 29, 2021 | Common Stock | SSaleDisposed | −82,505 | $1.16 | −$95,705.8 | 13,399,870 | Indirect | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −137,495 | $1.12 | −$153,994.4 | 13,262,375 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.